U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C10H6O2
Molecular Weight 158.1534
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 1,4-NAPHTHOQUINONE

SMILES

O=C1C=CC(=O)C2=C1C=CC=C2

InChI

InChIKey=FRASJONUBLZVQX-UHFFFAOYSA-N
InChI=1S/C10H6O2/c11-9-5-6-10(12)8-4-2-1-3-7(8)9/h1-6H

HIDE SMILES / InChI

Molecular Formula C10H6O2
Molecular Weight 158.1534
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

1,4-naphthoquinone is a chemical studied as a potential inhibitor of monoamine oxidase and DNA topoisomerase activities as well as acetyltransferase activity. 1,4-Naphthoquinone is a potent inhibitor of human cancer cell growth and angiogenesis.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
10.8 µM [IC50]
1.5 µM [Ki]
7.7 µM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Molecular modeling and 3D-QSAR studies in 2-aziridinyl-and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives as potential antimalarial agents.
2001
[Cytotoxicity of beta-lapachone, an naphthoquinone with possible therapeutic use].
2001
Bromination studies of the 2,3-dimethylnaphthazarin core allowing easy access to naphthazarin derivatives.
2001 Aug 10
A new naphthoquinone from Pyrola japonica.
2001 Dec
Association of quinone-induced platelet anti-aggregation with cytotoxicity.
2001 Jul
Quinone isomers of the WS-5995 antibiotics: synthetic antitumor agents that inhibit macromolecule synthesis, block nucleoside transport, induce DNA fragmentation, and decrease the growth and viability of L1210 leukemic cells more effectively than ellagic acid and genistein in vitro.
2001 Jun
Recruitment of a foreign quinone into the A1 site of photosystem I. In vivo replacement of plastoquinone-9 by media-supplemented naphthoquinones in phylloquinone biosynthetic pathway mutants of Synechocystis sp. PCC 6803.
2001 Oct 26
Inactivation of rat cytochrome P450 2D enzyme by a further metabolite of 4-hydroxypropranolol, the major and active metabolite of propranolol.
2001 Sep
[Studies on the inhibition of polyhydroxylated aromatic compounds against HIV-1 integrase].
2002 Apr
A new naphthoquinone from Polygonum aviculare.
2002 Apr
Lindbladione and related naphthoquinone pigments from a myxomycete Lindbladia tubulina.
2002 Aug
Chloroquinocin, a novel chlorinated naphthoquinone antibiotic from Streptomyces sp., LL-A9227.
2002 Dec
2-(Pyrrolidin-1-yl)-1,4-naphthoquinone and 2-phenylsulfanyl-3-(pyrrolidin-1-yl)-1,4-naphthoquinone.
2002 Dec
Placement and characterization of pairs of luminescent molecules in spatially separated regions of nanostructured thin films.
2002 Dec 4
Geranyl diphosphate:4-hydroxybenzoate geranyltransferase from Lithospermum erythrorhizon. Cloning and characterization of a ket enzyme in shikonin biosynthesis.
2002 Feb 22
Solubilization of a naphthoquinone derivative by hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and polyvinylpyrrolidone (PVP-K30). The influence of PVP-K30 and pH on solubilizing effect of HP-beta-CD.
2002 Jan-Feb
[Respiratory activity and naphthoquinone synthesis in the fungus Fusarium decemcellulare exposed to oxidative stress].
2002 Mar-Apr
Synthesis of 2-alkoxy 1,4-naphthoquinone derivatives as antiplatelet, antiinflammatory, and antiallergic agents.
2002 May
Three new naphthoquinone derivatives from Diospyros maritima Blume.
2002 May
Cyclooxygenase-2 inhibitory 1,4-naphthoquinones from Impatiens balsamina L.
2002 May
Why do co-solvents enhance the solubility of solutes in supercritical fluids? New evidence and opinion.
2002 Nov 15
Synthesis of monocarbenepalladium(0) complexes and their catalytic behavior in cross-coupling reactions of aryldiazonium salts.
2002 Sep 2
Feasibility of atmospheric pressure desorption/ionization on silicon mass spectrometry in analysis of drugs.
2003
Mechanisms for naphthalene removal during electrolytic aeration.
2003 Feb
Synthesis and biological evaluation of some new substituted naphthoquinones.
2003 Jun
Discriminating redox cycling and arylation pathways of reactive chemical toxicity in trout hepatocytes.
2003 Mar
Total syntheses of furaquinocin A, B, and E.
2003 Oct 29
Cytotoxicity and DNA topoisomerase inhibitory activity of benz[f]indole-4,9-dione analogs.
2003 Sep
A new naphthoquinone from Ceiba pentandra.
2003 Sep
Alternative quinone substrates and inhibitors of human electron-transfer flavoprotein-ubiquinone oxidoreductase.
2004 Mar 1
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: Rat LD50 (oral) 190mg/kg Mouse LD50 (intraperitoneal) 5500µg/kg Guinea Pig LD50 (oral) 400mg/kg
Rat LD50 (oral) 190mg/kg
Route of Administration: Oral
1,4-naphthoquinone exhibited cytotoxic activity against HepG2 cell line with the IC50 value of 13.75±0.74 uM. It exhibited very potent ABTS+ cation radical scavenging activity with IC50 value of 7.97 uM.
Substance Class Chemical
Created
by admin
on Fri Dec 15 19:02:36 GMT 2023
Edited
by admin
on Fri Dec 15 19:02:36 GMT 2023
Record UNII
RBF5ZU7R7K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
1,4-NAPHTHOQUINONE
HSDB   MI  
Systematic Name English
1,4-NAPHTHOQUINONE [HSDB]
Common Name English
NAPHTHOQUINONE, 1,4-
Systematic Name English
1,4-NAPHTHOQUINONE [MI]
Common Name English
.ALPHA.-NAPHTHOQUINONE
Common Name English
1,4-DIHYDRO-1,4-DIKETONAPHTHALENE
Systematic Name English
NSC-9583
Code English
1,4-NAPHTHALENEDIONE
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID5040704
Created by admin on Fri Dec 15 19:02:37 GMT 2023 , Edited by admin on Fri Dec 15 19:02:37 GMT 2023
PRIMARY
PUBCHEM
8530
Created by admin on Fri Dec 15 19:02:37 GMT 2023 , Edited by admin on Fri Dec 15 19:02:37 GMT 2023
PRIMARY
HSDB
2037
Created by admin on Fri Dec 15 19:02:37 GMT 2023 , Edited by admin on Fri Dec 15 19:02:37 GMT 2023
PRIMARY
NSC
9583
Created by admin on Fri Dec 15 19:02:37 GMT 2023 , Edited by admin on Fri Dec 15 19:02:37 GMT 2023
PRIMARY
DAILYMED
RBF5ZU7R7K
Created by admin on Fri Dec 15 19:02:37 GMT 2023 , Edited by admin on Fri Dec 15 19:02:37 GMT 2023
PRIMARY
ECHA (EC/EINECS)
204-977-6
Created by admin on Fri Dec 15 19:02:37 GMT 2023 , Edited by admin on Fri Dec 15 19:02:37 GMT 2023
PRIMARY
FDA UNII
RBF5ZU7R7K
Created by admin on Fri Dec 15 19:02:37 GMT 2023 , Edited by admin on Fri Dec 15 19:02:37 GMT 2023
PRIMARY
CHEBI
27418
Created by admin on Fri Dec 15 19:02:37 GMT 2023 , Edited by admin on Fri Dec 15 19:02:37 GMT 2023
PRIMARY
RXCUI
1602556
Created by admin on Fri Dec 15 19:02:37 GMT 2023 , Edited by admin on Fri Dec 15 19:02:37 GMT 2023
PRIMARY RxNorm
MERCK INDEX
m7750
Created by admin on Fri Dec 15 19:02:37 GMT 2023 , Edited by admin on Fri Dec 15 19:02:37 GMT 2023
PRIMARY Merck Index
WIKIPEDIA
1,4-NAPHTHOQUINONE
Created by admin on Fri Dec 15 19:02:37 GMT 2023 , Edited by admin on Fri Dec 15 19:02:37 GMT 2023
PRIMARY
CAS
130-15-4
Created by admin on Fri Dec 15 19:02:37 GMT 2023 , Edited by admin on Fri Dec 15 19:02:37 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
IN VITRO